Showing 2593–2604 of 2679 results

  • XENGLU MET XR 12.5/1000MG TAB14S

    XENGLU MET XR 12.5/1000MG TAB14S

    0 out of 5
    516.42

    Xenglu Met XR combines [active ingredients: Vildagliptin 12.5mg + Metformin HCl 1000mg], helping to manage blood sugar levels in adults with type 2 diabetes. It works by increasing insulin release and improving the body’s response to insulin, while reducing glucose production in the liver. Key Uses: Helps control high blood sugar in type 2 diabetes…

  • XEPAT OD  2.5ML DROP

    XEPAT OD 2.5ML DROP

    0 out of 5
    690

    XEPAT OD 2.5ML DROP is a sterile ophthalmic solution used for the treatment of ocular itching associated with allergic conjunctivitis (also known as hay fever eyes). The active ingredient is olopatadine, which is a dual-action drug. It acts as a selective histamine H1-receptor antagonist and a mast cell stabilizer.

  • XIGA 10MG TAB

    XIGA 10MG TAB

    0 out of 5
    322.50

    Xiga 10mg contains dapagliflozin, which helps remove extra glucose from the body through urine. It is used for controlling blood sugar in type 2 diabetes and also supports weight and blood pressure control. It should be taken regularly along with lifestyle changes. Medical advice is needed before use.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • XIGA 5MG TAB

    XIGA 5MG TAB

    0 out of 5
    217

    Xiga 5mg is used to manage high blood sugar in type 2 diabetic patients. It works by increasing the excretion of glucose from the body through urine. This helps improve blood sugar levels and supports heart and kidney health. It should be taken as prescribed by the doctor.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • XIGA MET 5/850MG TABLETS

    XIGA MET 5/850MG TABLETS

    0 out of 5
    272

    This tablet combines dapagliflozin and metformin to control blood sugar levels in type 2 diabetes. It reduces glucose production and increases its removal through urine. It helps improve overall blood sugar control and reduces risks of complications. It should be used with a proper diet and regular exercise.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • XIGA MET 5MG/1000MG TAB 14S

    XIGA MET 5MG/1000MG TAB 14S

    0 out of 5
    226.50

    This medicine is used to treat type 2 diabetes by controlling high blood sugar. It contains dapagliflozin and metformin, which work together to maintain glucose balance. It improves the body’s response to insulin and reduces glucose absorption in the intestines. It is taken once daily with meals as prescribed.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • XIGA MET XR 10/1000 TAB

    XIGA MET XR 10/1000 TAB

    0 out of 5
    577

    Xiga Met XR combines Sitagliptin (10mg), a DPP-4 inhibitor, and Metformin (1000mg), a biguanide, to treat type 2 diabetes. This combination helps control blood sugar levels by increasing insulin production and decreasing glucose production in the liver, improving insulin sensitivity. Key Uses: Management of type 2 diabetes (non-insulin-dependent diabetes) Helps control blood sugar levels in…

  • XIGA MET XR 5/500MG TABLET

    XIGA MET XR 5/500MG TABLET

    0 out of 5
    278.50

    Xiga Met XR is an extended-release tablet for managing type 2 diabetes. It slowly releases medicine to maintain stable blood sugar throughout the day. It lowers glucose production and increases its elimination from the body. It works best along with healthy eating and physical activity.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • XIGAMET XR 5/1000MG TABLET

    XIGAMET XR 5/1000MG TABLET

    0 out of 5
    281.50

    Xigamet XR controls blood sugar levels with its extended-release formula. It provides long-lasting effects to manage type 2 diabetes effectively. It helps prevent spikes in blood sugar after meals. Consistent use under medical advice helps avoid complications from uncontrolled diabetes.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page
  • XIKARAPID 8MG TAB

    XIKARAPID 8MG TAB

    0 out of 5
    353

    Xikarapid 8mg is used to relieve pain and inflammation in various conditions like arthritis, muscle pain, and injury-related swelling. It works by reducing substances that cause pain and inflammation. It provides quick relief and improves mobility. Should be taken only for short-term use as prescribed.

  • XILICA 50MG CAPS

    XILICA 50MG CAPS

    0 out of 5
    390

    XILICA 50MG CAPS is a medication containing the active ingredient pregabalin. It is an anticonvulsant and neuropathic pain agent. It works by binding to a specific subunit of voltage-gated calcium channels in the central nervous system, which helps to reduce the release of certain neurotransmitters involved in the transmission of pain signals.  

  • XOBIX 15MG TAB

    XOBIX 15MG TAB

    0 out of 5
    344

    Xobix 15mg is commonly used to relieve pain and inflammation in conditions like osteoarthritis and rheumatoid arthritis. It helps reduce swelling, stiffness, and joint pain. This medicine improves mobility and enhances the quality of life in patients with chronic pain. It should be taken with food as advised by a doctor.

    Select optionsLoading Done This product has multiple variants. The options may be chosen on the product page

End of content

End of content

The Categories provide a framework to which existing art information systems can be mapped and upon which new systems can be developed. In addition, the discussions in the CDWA identify vocabulary resources and descriptive practices that will make information residing in diverse systems both more compatible and more accessible.The use of the CDWA framework will contribute to the integrity and longevity of data and will facilitate its inevitable migration to new systems as informational technology continues to evolve. Above all, it will help to give end-users consistent, reliable access to information, regardless of the system in which it resides.